🇺🇸 FDA
Patent

US 9169182

Chrysophaentin analogs that inhibit FtsZ protein

granted A61KA61K31/055A61K31/085

Quick answer

US patent 9169182 (Chrysophaentin analogs that inhibit FtsZ protein) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Oct 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/055, A61K31/085, A61K45/06